Skip to main content
. 2004 Apr 19;2004(2):CD000967. doi: 10.1002/14651858.CD000967.pub2

UK 2003.

Trial name or title Unknown.
Methods  
Participants Diagnosis: people with schizophrenia. 
 N projected ˜ 240, current recruitment ˜120.
Interventions 1. Quetiapine: dose unknown. 
 2. Risperidone: dose unknown.
Outcomes Unknown.
Starting date Not known.
Contact information Unknown.
Notes Allocation: randomised. 
 Supported by a grant from AstraZeneca Pharmaceuticals. 
 Unclear if recruitment will continue.